rs149378938
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_006295.3(VARS1):c.3355C>T(p.Arg1119Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,612,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006295.3 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorder with microcephaly, seizures, and cortical atrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- combined oxidative phosphorylation defect type 20Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VARS1 | NM_006295.3 | c.3355C>T | p.Arg1119Cys | missense_variant | Exon 28 of 30 | ENST00000375663.8 | NP_006286.1 | |
| VARS1 | XM_005249362.3 | c.3358C>T | p.Arg1120Cys | missense_variant | Exon 28 of 30 | XP_005249419.1 | ||
| VARS1 | XM_047419296.1 | c.3358C>T | p.Arg1120Cys | missense_variant | Exon 27 of 29 | XP_047275252.1 | ||
| VARS1 | XM_047419297.1 | c.3355C>T | p.Arg1119Cys | missense_variant | Exon 27 of 29 | XP_047275253.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000204 AC: 5AN: 244528 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460350Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726544 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy Pathogenic:3
The homozygous p.Arg1119Cys variant in VARS1 was identified by our study in collaboration with the Gleeson Lab in an individual with neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy (PMID: 30755602). Please note that this variant may also be submitted to ClinVar by the Gleeson Lab. This variant was reported in 3 total Egyptian individuals with neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, segregated with disease in 2 affected relatives from 1 family (PMID: 30755602), and has been identified in 0.007% (1/14966) of African chromosomes, 0.005% (1/18238) of East Asian chromosomes, and 0.005% (1/21226) of European (Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs149378938). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 559839). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The presence of this variant in affected homozygotes increases the likelihood that the p.Arg1119Cys variant is pathogenic (PMID: 30755602). Multiple variants with the same function as p.Arg1119Cys variant have been reported in association with disease in the literature and the variant is located in a region of VARS1 that is essential to protein function, suggesting that this variant is in a functional domain and supports pathogenicity (PMID: 30755602). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM1, PM3 (Richards 2015). -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at